205 related articles for article (PubMed ID: 15256187)
1. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
Morris GL; Hammer AE; Kustra RP; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):509-12. PubMed ID: 15256187
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
Machado RA; García VF; Astencio AG; Cuartas VB
Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525
[TBL] [Abstract][Full Text] [Related]
3. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
Sale ME; Natarajan S; Biton V; Vuong A; Hammer AE; Messenheimer JA; Blum D
Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
[TBL] [Abstract][Full Text] [Related]
4. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
Montouris G; Abou-Khalil B
Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
[TBL] [Abstract][Full Text] [Related]
6. Open study evaluating lamotrigine efficacy and safety in add-on treatment and consecutive monotherapy in patients with carbamazepine- or valproate-resistant epilepsy.
Jozwiak S; Terczynski A
Seizure; 2000 Oct; 9(7):486-92. PubMed ID: 11034873
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
Kothare SV; Valencia I; Khurana DS; Hardison H; Melvin JJ; Legido A
Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
[TBL] [Abstract][Full Text] [Related]
8. [Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate].
Crespel A; Velizarova R; Genton P; Gélisse P
Therapie; 2009; 64(5):321-3. PubMed ID: 19863907
[TBL] [Abstract][Full Text] [Related]
9. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
[TBL] [Abstract][Full Text] [Related]
10. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
11. Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison.
Levisohn PM; Holland KD
Epilepsy Behav; 2007 Jun; 10(4):547-52. PubMed ID: 17482520
[TBL] [Abstract][Full Text] [Related]
12. Lamotrigine monotherapy compared with carbamazepine, phenytoin, or valproate monotherapy in patients with epilepsy.
Kaminow L; Schimschock JR; Hammer AE; Vuong A
Epilepsy Behav; 2003 Dec; 4(6):659-66. PubMed ID: 14698699
[TBL] [Abstract][Full Text] [Related]
13. Exacerbation of juvenile myoclonic epilepsy with lamotrigine.
Biraben A; Allain H; Scarabin JM; Schück S; Edan G
Neurology; 2000 Dec; 55(11):1758. PubMed ID: 11113246
[No Abstract] [Full Text] [Related]
14. [Exacerbation of tonicoclonic seizures in a juvenile myoclonic epileptic taking lamotrigine].
Maiga Y; Nogues B; Guillon B
Rev Neurol (Paris); 2006 Nov; 162(11):1125-7. PubMed ID: 17086150
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Chowdhury A; Brodie MJ
Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
[TBL] [Abstract][Full Text] [Related]
16. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
Milano C; Turco F; Pizzanelli C; Bonanni E; Siciliano G; Fornai F; Giorgi FS
Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017
[TBL] [Abstract][Full Text] [Related]
17. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy.
Biton V; Mirza W; Montouris G; Vuong A; Hammer AE; Barrett PS
Neurology; 2001 Jan; 56(2):172-7. PubMed ID: 11160951
[TBL] [Abstract][Full Text] [Related]
18. Conversion to lamotrigine monotherapy from valproate monotherapy in older adolescent patients with epilepsy.
Baumann RJ; Fakhoury TA; Kustra RP; Vuong A; Hammer AE; Messenheimer JA
Curr Med Res Opin; 2007 Oct; 23(10):2461-5. PubMed ID: 17727739
[TBL] [Abstract][Full Text] [Related]
19. Outcome of lamotrigine treatment in juvenile myoclonic epilepsy.
Bodenstein-Sachar H; Gandelman-Marton R; Ben-Zeev B; Chapman J; Blatt I
Acta Neurol Scand; 2011 Jul; 124(1):22-7. PubMed ID: 21208196
[TBL] [Abstract][Full Text] [Related]
20. A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy.
Park KM; Kim SH; Nho SK; Shin KJ; Park J; Ha SY; Kim SE
J Clin Neurosci; 2013 Aug; 20(8):1079-82. PubMed ID: 23673144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]